Is TherapeuticsMD Inc (TXMD) a Laggard in the Healthcare Sector?

The 14 rating InvestorsObserver gives to TherapeuticsMD Inc (TXMD) stock puts it near the bottom of the Healthcare sector. In addition to scoring higher than 12 percent of stocks in the Healthcare sector, TXMD’s 14 overall rating means the stock scores better than 14 of all stocks.

TXMD has an Overall Score of 14. Find out what this means to you and get the rest of the rankings on TXMD!

See Full TXMD Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 14 means the stock is more attractive than 14 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With TherapeuticsMD Inc Stock Today?

TherapeuticsMD Inc (TXMD) stock is unmoved 0.2% while the S&P 500 has fallen -0.04% as of 10:07 AM on Friday, Mar 22. TXMD is flat $0.00 from the previous closing price of $2.30 on volume of 4,452 shares. Over the past year the S&P 500 is higher by 32.68% while TXMD has fallen -35.93%. TXMD earned $7.27 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 0.32. Click Here to get the full Stock Report for TherapeuticsMD Inc stock.